ARANESP - Risk of Severe Skin Reactions: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Severe blistering, mucosal ulceration, and exfoliation cutaneous reactions, including life-threatening SJS and TEN have been reported in patients treated with ARANESP in the post-marketing setting.

Product safety